This cohort study examines whether liver function markers are associated with cognitive dysfunction and the amyloid, tau, and neurodegeneration biomarkers in individuals with Alzheimer disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.